Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification
- PMID: 31155284
- PMCID: PMC6562152
- DOI: 10.1016/j.ajhg.2019.04.008
Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification
Abstract
Optimal lysosome function requires maintenance of an acidic pH maintained by proton pumps in combination with a counterion transporter such as the Cl-/H+ exchanger, CLCN7 (ClC-7), encoded by CLCN7. The role of ClC-7 in maintaining lysosomal pH has been controversial. In this paper, we performed clinical and genetic evaluations of two children of different ethnicities. Both children had delayed myelination and development, organomegaly, and hypopigmentation, but neither had osteopetrosis. Whole-exome and -genome sequencing revealed a de novo c.2144A>G variant in CLCN7 in both affected children. This p.Tyr715Cys variant, located in the C-terminal domain of ClC-7, resulted in increased outward currents when it was heterologously expressed in Xenopus oocytes. Fibroblasts from probands displayed a lysosomal pH approximately 0.2 units lower than that of control cells, and treatment with chloroquine normalized the pH. Primary fibroblasts from both probands also exhibited markedly enlarged intracellular vacuoles; this finding was recapitulated by the overexpression of human p.Tyr715Cys CLCN7 in control fibroblasts, reflecting the dominant, gain-of-function nature of the variant. A mouse harboring the knock-in Clcn7 variant exhibited hypopigmentation, hepatomegaly resulting from abnormal storage, and enlarged vacuoles in cultured fibroblasts. Our results show that p.Tyr715Cys is a gain-of-function CLCN7 variant associated with developmental delay, organomegaly, and hypopigmentation resulting from lysosomal hyperacidity, abnormal storage, and enlarged intracellular vacuoles. Our data supports the hypothesis that the ClC-7 antiporter plays a critical role in maintaining lysosomal pH.
Keywords: ClC-7 antiporter; chloroquine; cutaneous albinism; lysosomal hyperacidity; lysosomal membrane counterion; lysosomal pH; lysosomal storage disease; oculocutaneous albinism.
Published by Elsevier Inc.
Figures
Similar articles
-
Impaired Autophagic Clearance with a Gain-of-Function Variant of the Lysosomal Cl-/H+ Exchanger ClC-7.Biomolecules. 2023 Dec 15;13(12):1799. doi: 10.3390/biom13121799. Biomolecules. 2023. PMID: 38136669 Free PMC article.
-
Gain-of-function variants in CLCN7 cause hypopigmentation and lysosomal storage disease.J Biol Chem. 2024 Jul;300(7):107437. doi: 10.1016/j.jbc.2024.107437. Epub 2024 Jun 3. J Biol Chem. 2024. PMID: 38838776 Free PMC article.
-
Multisystem disorder associated with a pathogenic variant in CLCN7 in the absence of osteopetrosis.Mol Genet Genomic Med. 2024 Jul;12(7):e2494. doi: 10.1002/mgg3.2494. Mol Genet Genomic Med. 2024. PMID: 39056574 Free PMC article.
-
The Role of the Lysosomal Cl-/H+ Antiporter ClC-7 in Osteopetrosis and Neurodegeneration.Cells. 2022 Jan 21;11(3):366. doi: 10.3390/cells11030366. Cells. 2022. PMID: 35159175 Free PMC article. Review.
-
Neurodegeneration Upon Dysfunction of Endosomal/Lysosomal CLC Chloride Transporters.Front Cell Dev Biol. 2021 Feb 23;9:639231. doi: 10.3389/fcell.2021.639231. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33708769 Free PMC article. Review.
Cited by
-
West Syndrome Caused By a Chloride/Proton Exchange-Uncoupling CLCN6 Mutation Related to Autophagic-Lysosomal Dysfunction.Mol Neurobiol. 2021 Jun;58(6):2990-2999. doi: 10.1007/s12035-021-02291-3. Epub 2021 Feb 16. Mol Neurobiol. 2021. PMID: 33590434
-
Impaired Autophagic Clearance with a Gain-of-Function Variant of the Lysosomal Cl-/H+ Exchanger ClC-7.Biomolecules. 2023 Dec 15;13(12):1799. doi: 10.3390/biom13121799. Biomolecules. 2023. PMID: 38136669 Free PMC article.
-
Physiological Functions of the Volume-Regulated Anion Channel VRAC/LRRC8 and the Proton-Activated Chloride Channel ASOR/TMEM206.Handb Exp Pharmacol. 2024;283:181-218. doi: 10.1007/164_2023_673. Handb Exp Pharmacol. 2024. PMID: 37468723
-
Two-pore channel 2 is required for soluble adenylyl cyclase-dependent regulation of melanosomal pH and melanin synthesis.Pigment Cell Melanoma Res. 2024 Sep;37(5):656-666. doi: 10.1111/pcmr.13177. Epub 2024 Jun 6. Pigment Cell Melanoma Res. 2024. PMID: 38844435
-
Chloroquine increases osteoclast activity in vitro but does not improve the osteopetrotic bone phenotype of ADO2 mice.Bone. 2021 Dec;153:116160. doi: 10.1016/j.bone.2021.116160. Epub 2021 Aug 28. Bone. 2021. PMID: 34464779 Free PMC article.
References
-
- Devuyst O., Christie P.T., Courtoy P.J., Beauwens R., Thakker R.V. Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent’s disease. Hum. Mol. Genet. 1999;8:247–257. - PubMed
- Devuyst, O., Christie, P.T., Courtoy, P.J., Beauwens, R., and Thakker, R.V. (1999). Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent’s disease. Hum. Mol. Genet. 8, 247-257. - PubMed
-
- Kasper D., Planells-Cases R., Fuhrmann J.C., Scheel O., Zeitz O., Ruether K., Schmitt A., Poët M., Steinfeld R., Schweizer M. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 2005;24:1079–1091. - PMC - PubMed
- Kasper, D., Planells-Cases, R., Fuhrmann, J.C., Scheel, O., Zeitz, O., Ruether, K., Schmitt, A., Poet, M., Steinfeld, R., Schweizer, M., et al. (2005). Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 24, 1079-1091. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
